Equinox International

Equinox International is a British medical cannabis company dedicated to producing high-quality, domestically grown medical cannabis products. As the UK’s first vertically integrated, ‘land-to-brand’ medical cannabis company, it operates under strict EU-GMP standards. Since its establishment in 2015, Equinox has combined industry experience with scientific expertise to develop innovative cannabis strains and formulations aimed at improving patient care and enhancing quality of life.

The company focuses on the cultivation, research, and supply of medical cannabis and cannabinoid compounds prescribed by healthcare professionals. Equinox emphasizes scientific validation of cannabis's healing properties and employs advanced agricultural techniques and proprietary formulations to ensure consistent quality. It collaborates with governments across various regions to support the establishment of legal medical cannabis programs and promote best practices in the industry, ultimately serving British patients seeking alternative treatments for various medical conditions.